nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Dizziness—Vandetanib—thyroid cancer	0.00212	0.00212	CcSEcCtD
Salbutamol—Skin disorder—Sorafenib—thyroid cancer	0.0021	0.0021	CcSEcCtD
Salbutamol—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Salbutamol—Anorexia—Sorafenib—thyroid cancer	0.00206	0.00206	CcSEcCtD
Salbutamol—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00205	0.00205	CcSEcCtD
Salbutamol—Vomiting—Vandetanib—thyroid cancer	0.00203	0.00203	CcSEcCtD
Salbutamol—Eructation—Doxorubicin—thyroid cancer	0.00203	0.00203	CcSEcCtD
Salbutamol—Rash—Vandetanib—thyroid cancer	0.00202	0.00202	CcSEcCtD
Salbutamol—Dermatitis—Vandetanib—thyroid cancer	0.00202	0.00202	CcSEcCtD
Salbutamol—Headache—Vandetanib—thyroid cancer	0.002	0.002	CcSEcCtD
Salbutamol—Pulmonary oedema—Epirubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00197	0.00197	CcSEcCtD
Salbutamol—Hypertonia—Epirubicin—thyroid cancer	0.00196	0.00196	CcSEcCtD
Salbutamol—Mental disability—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Salbutamol—Dyspnoea—Sorafenib—thyroid cancer	0.00192	0.00192	CcSEcCtD
Salbutamol—Lymphadenopathy—Epirubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Salbutamol—Nausea—Vandetanib—thyroid cancer	0.0019	0.0019	CcSEcCtD
Salbutamol—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Salbutamol—Dyspepsia—Sorafenib—thyroid cancer	0.0019	0.0019	CcSEcCtD
Salbutamol—Decreased appetite—Sorafenib—thyroid cancer	0.00188	0.00188	CcSEcCtD
Salbutamol—Diabetes mellitus—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00186	0.00186	CcSEcCtD
Salbutamol—Fatigue—Sorafenib—thyroid cancer	0.00186	0.00186	CcSEcCtD
Salbutamol—Pain—Sorafenib—thyroid cancer	0.00185	0.00185	CcSEcCtD
Salbutamol—Constipation—Sorafenib—thyroid cancer	0.00185	0.00185	CcSEcCtD
Salbutamol—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Salbutamol—Hypertonia—Doxorubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Salbutamol—Eczema—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Salbutamol—Mental disability—Doxorubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Salbutamol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00176	0.00176	CcSEcCtD
Salbutamol—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Salbutamol—Increased appetite—Epirubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Salbutamol—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Salbutamol—Urticaria—Sorafenib—thyroid cancer	0.00171	0.00171	CcSEcCtD
Salbutamol—Abdominal pain—Sorafenib—thyroid cancer	0.00171	0.00171	CcSEcCtD
Salbutamol—Body temperature increased—Sorafenib—thyroid cancer	0.00171	0.00171	CcSEcCtD
Salbutamol—Eczema—Doxorubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Salbutamol—Hypoglycaemia—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Salbutamol—Increased appetite—Doxorubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Salbutamol—Affect lability—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Salbutamol—Migraine—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Salbutamol—Hypersensitivity—Sorafenib—thyroid cancer	0.00159	0.00159	CcSEcCtD
Salbutamol—Asthenia—Sorafenib—thyroid cancer	0.00155	0.00155	CcSEcCtD
Salbutamol—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Salbutamol—Mood swings—Epirubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Salbutamol—Pruritus—Sorafenib—thyroid cancer	0.00153	0.00153	CcSEcCtD
Salbutamol—Ataxia—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Salbutamol—Abdominal pain upper—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Salbutamol—Migraine—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Salbutamol—Affect lability—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Salbutamol—Hypokalaemia—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Salbutamol—Diarrhoea—Sorafenib—thyroid cancer	0.00148	0.00148	CcSEcCtD
Salbutamol—Nasopharyngitis—Epirubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Salbutamol—Dizziness—Sorafenib—thyroid cancer	0.00143	0.00143	CcSEcCtD
Salbutamol—Mood swings—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Salbutamol—Abdominal distension—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Salbutamol—Ataxia—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Salbutamol—Asthma—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Salbutamol—Influenza—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Salbutamol—Vomiting—Sorafenib—thyroid cancer	0.00137	0.00137	CcSEcCtD
Salbutamol—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Salbutamol—Hypokalaemia—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Salbutamol—Angina pectoris—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Salbutamol—Rash—Sorafenib—thyroid cancer	0.00136	0.00136	CcSEcCtD
Salbutamol—Dermatitis—Sorafenib—thyroid cancer	0.00136	0.00136	CcSEcCtD
Salbutamol—Headache—Sorafenib—thyroid cancer	0.00135	0.00135	CcSEcCtD
Salbutamol—Bronchitis—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Salbutamol—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Salbutamol—Dysuria—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Salbutamol—Abdominal distension—Doxorubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Salbutamol—Asthma—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Salbutamol—Influenza—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Salbutamol—Nausea—Sorafenib—thyroid cancer	0.00128	0.00128	CcSEcCtD
Salbutamol—Hyperglycaemia—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Salbutamol—Angina pectoris—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Salbutamol—Drowsiness—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Salbutamol—Bronchitis—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Salbutamol—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Salbutamol—Stomatitis—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Salbutamol—Jaundice—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Salbutamol—Conjunctivitis—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Salbutamol—Urinary tract infection—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Salbutamol—Dysuria—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Salbutamol—Sweating—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Salbutamol—Haematuria—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Salbutamol—Epistaxis—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Salbutamol—Sinusitis—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Salbutamol—Hyperglycaemia—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Salbutamol—Drowsiness—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Salbutamol—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Salbutamol—Haemoglobin—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Salbutamol—Stomatitis—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Salbutamol—Jaundice—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Salbutamol—Rhinitis—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Salbutamol—Conjunctivitis—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Salbutamol—Urinary tract infection—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Salbutamol—Haemorrhage—Epirubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Salbutamol—Hypoaesthesia—Epirubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Salbutamol—Pharyngitis—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Salbutamol—Sweating—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Salbutamol—Urinary tract disorder—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Salbutamol—Haematuria—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Salbutamol—Connective tissue disorder—Epirubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Salbutamol—Urethral disorder—Epirubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Salbutamol—Epistaxis—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Salbutamol—Sinusitis—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Salbutamol—Tinnitus—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Salbutamol—Haemoglobin—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Salbutamol—Cardiac disorder—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Salbutamol—Flushing—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Salbutamol—Rhinitis—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Salbutamol—Haemorrhage—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Salbutamol—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Salbutamol—Pharyngitis—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Salbutamol—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Salbutamol—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Salbutamol—Angiopathy—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Salbutamol—Urethral disorder—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Salbutamol—Immune system disorder—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Salbutamol—Mediastinal disorder—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Salbutamol—Chills—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Salbutamol—Arrhythmia—Epirubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Salbutamol—Mental disorder—Epirubicin—thyroid cancer	0.000983	0.000983	CcSEcCtD
Salbutamol—Malnutrition—Epirubicin—thyroid cancer	0.000977	0.000977	CcSEcCtD
Salbutamol—Tinnitus—Doxorubicin—thyroid cancer	0.000968	0.000968	CcSEcCtD
Salbutamol—Flushing—Doxorubicin—thyroid cancer	0.000964	0.000964	CcSEcCtD
Salbutamol—Cardiac disorder—Doxorubicin—thyroid cancer	0.000964	0.000964	CcSEcCtD
Salbutamol—Flatulence—Epirubicin—thyroid cancer	0.000963	0.000963	CcSEcCtD
Salbutamol—Tension—Epirubicin—thyroid cancer	0.000959	0.000959	CcSEcCtD
Salbutamol—Dysgeusia—Epirubicin—thyroid cancer	0.000957	0.000957	CcSEcCtD
Salbutamol—Nervousness—Epirubicin—thyroid cancer	0.000949	0.000949	CcSEcCtD
Salbutamol—Back pain—Epirubicin—thyroid cancer	0.000945	0.000945	CcSEcCtD
Salbutamol—Angiopathy—Doxorubicin—thyroid cancer	0.000942	0.000942	CcSEcCtD
Salbutamol—Muscle spasms—Epirubicin—thyroid cancer	0.000939	0.000939	CcSEcCtD
Salbutamol—Immune system disorder—Doxorubicin—thyroid cancer	0.000938	0.000938	CcSEcCtD
Salbutamol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000936	0.000936	CcSEcCtD
Salbutamol—Chills—Doxorubicin—thyroid cancer	0.000932	0.000932	CcSEcCtD
Salbutamol—Arrhythmia—Doxorubicin—thyroid cancer	0.000928	0.000928	CcSEcCtD
Salbutamol—Mental disorder—Doxorubicin—thyroid cancer	0.00091	0.00091	CcSEcCtD
Salbutamol—Ill-defined disorder—Epirubicin—thyroid cancer	0.000907	0.000907	CcSEcCtD
Salbutamol—Malnutrition—Doxorubicin—thyroid cancer	0.000904	0.000904	CcSEcCtD
Salbutamol—Agitation—Epirubicin—thyroid cancer	0.000898	0.000898	CcSEcCtD
Salbutamol—Flatulence—Doxorubicin—thyroid cancer	0.000891	0.000891	CcSEcCtD
Salbutamol—Tension—Doxorubicin—thyroid cancer	0.000887	0.000887	CcSEcCtD
Salbutamol—Dysgeusia—Doxorubicin—thyroid cancer	0.000885	0.000885	CcSEcCtD
Salbutamol—Malaise—Epirubicin—thyroid cancer	0.000881	0.000881	CcSEcCtD
Salbutamol—Nervousness—Doxorubicin—thyroid cancer	0.000878	0.000878	CcSEcCtD
Salbutamol—Vertigo—Epirubicin—thyroid cancer	0.000878	0.000878	CcSEcCtD
Salbutamol—Syncope—Epirubicin—thyroid cancer	0.000876	0.000876	CcSEcCtD
Salbutamol—Back pain—Doxorubicin—thyroid cancer	0.000875	0.000875	CcSEcCtD
Salbutamol—Muscle spasms—Doxorubicin—thyroid cancer	0.000869	0.000869	CcSEcCtD
Salbutamol—Palpitations—Epirubicin—thyroid cancer	0.000864	0.000864	CcSEcCtD
Salbutamol—Loss of consciousness—Epirubicin—thyroid cancer	0.000859	0.000859	CcSEcCtD
Salbutamol—Cough—Epirubicin—thyroid cancer	0.000853	0.000853	CcSEcCtD
Salbutamol—Hypertension—Epirubicin—thyroid cancer	0.000844	0.000844	CcSEcCtD
Salbutamol—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000839	0.000839	CcSEcCtD
Salbutamol—Myalgia—Epirubicin—thyroid cancer	0.000832	0.000832	CcSEcCtD
Salbutamol—Chest pain—Epirubicin—thyroid cancer	0.000832	0.000832	CcSEcCtD
Salbutamol—Arthralgia—Epirubicin—thyroid cancer	0.000832	0.000832	CcSEcCtD
Salbutamol—Agitation—Doxorubicin—thyroid cancer	0.000831	0.000831	CcSEcCtD
Salbutamol—Anxiety—Epirubicin—thyroid cancer	0.000829	0.000829	CcSEcCtD
Salbutamol—Discomfort—Epirubicin—thyroid cancer	0.000822	0.000822	CcSEcCtD
Salbutamol—Malaise—Doxorubicin—thyroid cancer	0.000815	0.000815	CcSEcCtD
Salbutamol—Dry mouth—Epirubicin—thyroid cancer	0.000814	0.000814	CcSEcCtD
Salbutamol—Vertigo—Doxorubicin—thyroid cancer	0.000812	0.000812	CcSEcCtD
Salbutamol—Syncope—Doxorubicin—thyroid cancer	0.000811	0.000811	CcSEcCtD
Salbutamol—Palpitations—Doxorubicin—thyroid cancer	0.000799	0.000799	CcSEcCtD
Salbutamol—Anaphylactic shock—Epirubicin—thyroid cancer	0.000798	0.000798	CcSEcCtD
Salbutamol—Oedema—Epirubicin—thyroid cancer	0.000798	0.000798	CcSEcCtD
Salbutamol—Loss of consciousness—Doxorubicin—thyroid cancer	0.000795	0.000795	CcSEcCtD
Salbutamol—Infection—Epirubicin—thyroid cancer	0.000792	0.000792	CcSEcCtD
Salbutamol—Cough—Doxorubicin—thyroid cancer	0.000789	0.000789	CcSEcCtD
Salbutamol—Shock—Epirubicin—thyroid cancer	0.000785	0.000785	CcSEcCtD
Salbutamol—Nervous system disorder—Epirubicin—thyroid cancer	0.000782	0.000782	CcSEcCtD
Salbutamol—Hypertension—Doxorubicin—thyroid cancer	0.000781	0.000781	CcSEcCtD
Salbutamol—Tachycardia—Epirubicin—thyroid cancer	0.000778	0.000778	CcSEcCtD
Salbutamol—Skin disorder—Epirubicin—thyroid cancer	0.000775	0.000775	CcSEcCtD
Salbutamol—Hyperhidrosis—Epirubicin—thyroid cancer	0.000771	0.000771	CcSEcCtD
Salbutamol—Chest pain—Doxorubicin—thyroid cancer	0.00077	0.00077	CcSEcCtD
Salbutamol—Arthralgia—Doxorubicin—thyroid cancer	0.00077	0.00077	CcSEcCtD
Salbutamol—Myalgia—Doxorubicin—thyroid cancer	0.00077	0.00077	CcSEcCtD
Salbutamol—Anxiety—Doxorubicin—thyroid cancer	0.000767	0.000767	CcSEcCtD
Salbutamol—Discomfort—Doxorubicin—thyroid cancer	0.000761	0.000761	CcSEcCtD
Salbutamol—Anorexia—Epirubicin—thyroid cancer	0.00076	0.00076	CcSEcCtD
Salbutamol—Dry mouth—Doxorubicin—thyroid cancer	0.000753	0.000753	CcSEcCtD
Salbutamol—Hypotension—Epirubicin—thyroid cancer	0.000745	0.000745	CcSEcCtD
Salbutamol—Oedema—Doxorubicin—thyroid cancer	0.000738	0.000738	CcSEcCtD
Salbutamol—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000738	0.000738	CcSEcCtD
Salbutamol—Infection—Doxorubicin—thyroid cancer	0.000733	0.000733	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000727	0.000727	CcSEcCtD
Salbutamol—Shock—Doxorubicin—thyroid cancer	0.000726	0.000726	CcSEcCtD
Salbutamol—Nervous system disorder—Doxorubicin—thyroid cancer	0.000724	0.000724	CcSEcCtD
Salbutamol—Insomnia—Epirubicin—thyroid cancer	0.000721	0.000721	CcSEcCtD
Salbutamol—Tachycardia—Doxorubicin—thyroid cancer	0.00072	0.00072	CcSEcCtD
Salbutamol—Skin disorder—Doxorubicin—thyroid cancer	0.000717	0.000717	CcSEcCtD
Salbutamol—Paraesthesia—Epirubicin—thyroid cancer	0.000716	0.000716	CcSEcCtD
Salbutamol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000713	0.000713	CcSEcCtD
Salbutamol—Dyspnoea—Epirubicin—thyroid cancer	0.000711	0.000711	CcSEcCtD
Salbutamol—Somnolence—Epirubicin—thyroid cancer	0.000709	0.000709	CcSEcCtD
Salbutamol—Anorexia—Doxorubicin—thyroid cancer	0.000703	0.000703	CcSEcCtD
Salbutamol—Dyspepsia—Epirubicin—thyroid cancer	0.000702	0.000702	CcSEcCtD
Salbutamol—Decreased appetite—Epirubicin—thyroid cancer	0.000693	0.000693	CcSEcCtD
Salbutamol—Hypotension—Doxorubicin—thyroid cancer	0.00069	0.00069	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000689	0.000689	CcSEcCtD
Salbutamol—Fatigue—Epirubicin—thyroid cancer	0.000688	0.000688	CcSEcCtD
Salbutamol—Constipation—Epirubicin—thyroid cancer	0.000682	0.000682	CcSEcCtD
Salbutamol—Pain—Epirubicin—thyroid cancer	0.000682	0.000682	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000672	0.000672	CcSEcCtD
Salbutamol—Insomnia—Doxorubicin—thyroid cancer	0.000667	0.000667	CcSEcCtD
Salbutamol—Paraesthesia—Doxorubicin—thyroid cancer	0.000663	0.000663	CcSEcCtD
Salbutamol—Dyspnoea—Doxorubicin—thyroid cancer	0.000658	0.000658	CcSEcCtD
Salbutamol—Feeling abnormal—Epirubicin—thyroid cancer	0.000657	0.000657	CcSEcCtD
Salbutamol—Somnolence—Doxorubicin—thyroid cancer	0.000656	0.000656	CcSEcCtD
Salbutamol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000652	0.000652	CcSEcCtD
Salbutamol—Dyspepsia—Doxorubicin—thyroid cancer	0.00065	0.00065	CcSEcCtD
Salbutamol—Decreased appetite—Doxorubicin—thyroid cancer	0.000641	0.000641	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000637	0.000637	CcSEcCtD
Salbutamol—Fatigue—Doxorubicin—thyroid cancer	0.000636	0.000636	CcSEcCtD
Salbutamol—Urticaria—Epirubicin—thyroid cancer	0.000634	0.000634	CcSEcCtD
Salbutamol—Constipation—Doxorubicin—thyroid cancer	0.000631	0.000631	CcSEcCtD
Salbutamol—Pain—Doxorubicin—thyroid cancer	0.000631	0.000631	CcSEcCtD
Salbutamol—Abdominal pain—Epirubicin—thyroid cancer	0.00063	0.00063	CcSEcCtD
Salbutamol—Body temperature increased—Epirubicin—thyroid cancer	0.00063	0.00063	CcSEcCtD
Salbutamol—Feeling abnormal—Doxorubicin—thyroid cancer	0.000608	0.000608	CcSEcCtD
Salbutamol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000603	0.000603	CcSEcCtD
Salbutamol—Hypersensitivity—Epirubicin—thyroid cancer	0.000588	0.000588	CcSEcCtD
Salbutamol—Urticaria—Doxorubicin—thyroid cancer	0.000586	0.000586	CcSEcCtD
Salbutamol—Body temperature increased—Doxorubicin—thyroid cancer	0.000583	0.000583	CcSEcCtD
Salbutamol—Abdominal pain—Doxorubicin—thyroid cancer	0.000583	0.000583	CcSEcCtD
Salbutamol—Asthenia—Epirubicin—thyroid cancer	0.000572	0.000572	CcSEcCtD
Salbutamol—Pruritus—Epirubicin—thyroid cancer	0.000564	0.000564	CcSEcCtD
Salbutamol—Diarrhoea—Epirubicin—thyroid cancer	0.000546	0.000546	CcSEcCtD
Salbutamol—Hypersensitivity—Doxorubicin—thyroid cancer	0.000544	0.000544	CcSEcCtD
Salbutamol—Asthenia—Doxorubicin—thyroid cancer	0.000529	0.000529	CcSEcCtD
Salbutamol—Dizziness—Epirubicin—thyroid cancer	0.000527	0.000527	CcSEcCtD
Salbutamol—Pruritus—Doxorubicin—thyroid cancer	0.000522	0.000522	CcSEcCtD
Salbutamol—Vomiting—Epirubicin—thyroid cancer	0.000507	0.000507	CcSEcCtD
Salbutamol—Diarrhoea—Doxorubicin—thyroid cancer	0.000505	0.000505	CcSEcCtD
Salbutamol—Rash—Epirubicin—thyroid cancer	0.000503	0.000503	CcSEcCtD
Salbutamol—Dermatitis—Epirubicin—thyroid cancer	0.000502	0.000502	CcSEcCtD
Salbutamol—Headache—Epirubicin—thyroid cancer	0.0005	0.0005	CcSEcCtD
Salbutamol—Dizziness—Doxorubicin—thyroid cancer	0.000488	0.000488	CcSEcCtD
Salbutamol—Nausea—Epirubicin—thyroid cancer	0.000474	0.000474	CcSEcCtD
Salbutamol—Vomiting—Doxorubicin—thyroid cancer	0.000469	0.000469	CcSEcCtD
Salbutamol—Rash—Doxorubicin—thyroid cancer	0.000465	0.000465	CcSEcCtD
Salbutamol—Dermatitis—Doxorubicin—thyroid cancer	0.000465	0.000465	CcSEcCtD
Salbutamol—Headache—Doxorubicin—thyroid cancer	0.000462	0.000462	CcSEcCtD
Salbutamol—Nausea—Doxorubicin—thyroid cancer	0.000438	0.000438	CcSEcCtD
